Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Orphan Drug Designation Granted for Plasma-Derived Hemopexin Therapy for Sickle Cell Disease

americanpharmaceuticalreviewNovember 11, 2020

Tag: CSL Behring , sickle cell disease , CSL889 , hemopexin

PharmaSources Customer Service